The promise of genetic testing to guide more effective treatment for millions of older and disabled Americans suffering from depression has shifted from a futuristic vision to a practical reality. Read more.
GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests Retrospective Chart Review Also Showed GeneSight Results Can... Read more.
Assurex Health today announced that the U.S. Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract as a government supplier, effective June 15, 2014, making the GeneSight® Psychotropic test available for use in VA facilities nationwide. The Veterans Health Administration is America’s largest integrated health care system with more than 1,400 sites of care, serving almost nine million veterans each year. Read more.
Your browser is not supported by mygenesight.com.
Please upgrade to a current version or use a different browser. The following browser versions are supported: